Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies

S. Peifang, G. L. Pira, D. Fenoglio, S. Harris, M. G. Costa, V. Venturino, V. Dessi, G. Layton, J. Laman, J. G. Huisman, F. Manca

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Recombinant virus-like particles (VLP), formed by the yeast Ty p1 protein, carrying the HIV gp120 V3 loop on their surface (V3-VLP) have been tested in vitro for immunogenicity and antigenicity by using VLP p1-specific human CD4+ T cell lines and crones. VLP-specific human T cell lines and crones were generated from normal individuals, indicating that VLP-specific precursor cells present in the peripheral lymphocyte pool can be induced to expand clonally upon antigen challenge in vitro, in the absence of previous immunization. It was also shown that V3-specific polyclonal antibodies enhance V3-VLP-induced activation of VLP-specific T cell clones. Antibody-dependent potentiation has been shown previously in other antigen systems, and it depends on enhanced uptake of complexed antigen by Fc receptor-positive antigen-presenting cells. Since in this case antigen is internalized by presenting cells as a complex, it can be inferred that a similar event of antibody-mediated antigen uptake can take place with V3-specific B cells, resulting in presentation by the B cells of T helper epitopes derived from processing of the VLP p1 moiety. This suggests that T helper cells specific for the carrier VLP p1 protein can be activated to provide help to V3-specific B cells in the presence of the appropriate antigen construct.

Original languageEnglish
Pages (from-to)361-366
Number of pages6
JournalClinical and Experimental Immunology
Volume97
Issue number3
Publication statusPublished - 1994

Fingerprint

Virion
Clone Cells
HIV
T-Lymphocytes
Antibodies
Antigens
B-Lymphocytes
HIV Envelope Protein gp120
Cell Line
Antigen Receptors
Fc Receptors
Antigen-Presenting Cells
Helper-Inducer T-Lymphocytes
Epitopes
Immunization
Lymphocytes

Keywords

  • HIV
  • Intramolecular help
  • Neutralizing antibodies
  • T clones
  • Virus-like particles

ASJC Scopus subject areas

  • Immunology

Cite this

Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies. / Peifang, S.; Pira, G. L.; Fenoglio, D.; Harris, S.; Costa, M. G.; Venturino, V.; Dessi, V.; Layton, G.; Laman, J.; Huisman, J. G.; Manca, F.

In: Clinical and Experimental Immunology, Vol. 97, No. 3, 1994, p. 361-366.

Research output: Contribution to journalArticle

Peifang, S. ; Pira, G. L. ; Fenoglio, D. ; Harris, S. ; Costa, M. G. ; Venturino, V. ; Dessi, V. ; Layton, G. ; Laman, J. ; Huisman, J. G. ; Manca, F. / Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies. In: Clinical and Experimental Immunology. 1994 ; Vol. 97, No. 3. pp. 361-366.
@article{39b5661589224519b63ccc0b03d2ba78,
title = "Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies",
abstract = "Recombinant virus-like particles (VLP), formed by the yeast Ty p1 protein, carrying the HIV gp120 V3 loop on their surface (V3-VLP) have been tested in vitro for immunogenicity and antigenicity by using VLP p1-specific human CD4+ T cell lines and crones. VLP-specific human T cell lines and crones were generated from normal individuals, indicating that VLP-specific precursor cells present in the peripheral lymphocyte pool can be induced to expand clonally upon antigen challenge in vitro, in the absence of previous immunization. It was also shown that V3-specific polyclonal antibodies enhance V3-VLP-induced activation of VLP-specific T cell clones. Antibody-dependent potentiation has been shown previously in other antigen systems, and it depends on enhanced uptake of complexed antigen by Fc receptor-positive antigen-presenting cells. Since in this case antigen is internalized by presenting cells as a complex, it can be inferred that a similar event of antibody-mediated antigen uptake can take place with V3-specific B cells, resulting in presentation by the B cells of T helper epitopes derived from processing of the VLP p1 moiety. This suggests that T helper cells specific for the carrier VLP p1 protein can be activated to provide help to V3-specific B cells in the presence of the appropriate antigen construct.",
keywords = "HIV, Intramolecular help, Neutralizing antibodies, T clones, Virus-like particles",
author = "S. Peifang and Pira, {G. L.} and D. Fenoglio and S. Harris and Costa, {M. G.} and V. Venturino and V. Dessi and G. Layton and J. Laman and Huisman, {J. G.} and F. Manca",
year = "1994",
language = "English",
volume = "97",
pages = "361--366",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies

AU - Peifang, S.

AU - Pira, G. L.

AU - Fenoglio, D.

AU - Harris, S.

AU - Costa, M. G.

AU - Venturino, V.

AU - Dessi, V.

AU - Layton, G.

AU - Laman, J.

AU - Huisman, J. G.

AU - Manca, F.

PY - 1994

Y1 - 1994

N2 - Recombinant virus-like particles (VLP), formed by the yeast Ty p1 protein, carrying the HIV gp120 V3 loop on their surface (V3-VLP) have been tested in vitro for immunogenicity and antigenicity by using VLP p1-specific human CD4+ T cell lines and crones. VLP-specific human T cell lines and crones were generated from normal individuals, indicating that VLP-specific precursor cells present in the peripheral lymphocyte pool can be induced to expand clonally upon antigen challenge in vitro, in the absence of previous immunization. It was also shown that V3-specific polyclonal antibodies enhance V3-VLP-induced activation of VLP-specific T cell clones. Antibody-dependent potentiation has been shown previously in other antigen systems, and it depends on enhanced uptake of complexed antigen by Fc receptor-positive antigen-presenting cells. Since in this case antigen is internalized by presenting cells as a complex, it can be inferred that a similar event of antibody-mediated antigen uptake can take place with V3-specific B cells, resulting in presentation by the B cells of T helper epitopes derived from processing of the VLP p1 moiety. This suggests that T helper cells specific for the carrier VLP p1 protein can be activated to provide help to V3-specific B cells in the presence of the appropriate antigen construct.

AB - Recombinant virus-like particles (VLP), formed by the yeast Ty p1 protein, carrying the HIV gp120 V3 loop on their surface (V3-VLP) have been tested in vitro for immunogenicity and antigenicity by using VLP p1-specific human CD4+ T cell lines and crones. VLP-specific human T cell lines and crones were generated from normal individuals, indicating that VLP-specific precursor cells present in the peripheral lymphocyte pool can be induced to expand clonally upon antigen challenge in vitro, in the absence of previous immunization. It was also shown that V3-specific polyclonal antibodies enhance V3-VLP-induced activation of VLP-specific T cell clones. Antibody-dependent potentiation has been shown previously in other antigen systems, and it depends on enhanced uptake of complexed antigen by Fc receptor-positive antigen-presenting cells. Since in this case antigen is internalized by presenting cells as a complex, it can be inferred that a similar event of antibody-mediated antigen uptake can take place with V3-specific B cells, resulting in presentation by the B cells of T helper epitopes derived from processing of the VLP p1 moiety. This suggests that T helper cells specific for the carrier VLP p1 protein can be activated to provide help to V3-specific B cells in the presence of the appropriate antigen construct.

KW - HIV

KW - Intramolecular help

KW - Neutralizing antibodies

KW - T clones

KW - Virus-like particles

UR - http://www.scopus.com/inward/record.url?scp=0027999043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027999043&partnerID=8YFLogxK

M3 - Article

VL - 97

SP - 361

EP - 366

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 3

ER -